Cannabis Laws in Belgium

Legal Framework: From 1921 to the 2024 Reform

Belgium’s cannabis policy history stretches from the Act of 24 February 1921 on the traffic in poisonous substances, sleeping potions, narcotics, and disinfectants — which formed the basis of Belgian drug law for most of the 20th century — to a series of progressive reforms beginning in the early 2000s that have gradually reduced but not eliminated criminal consequences for personal cannabis use.

The 2003 Circular: Decriminalization in Practice

The key legal development was the Ministerial Circular of 16 May 2003 issued jointly by the Minister of Justice and the College of Public Prosecutors. The circular instructed police and prosecutors to treat personal possession of up to 3 grams of cannabis as the lowest enforcement priority — effectively decriminalizing small-scale personal use without changing the underlying law.

The 2003 circular was controversial at the time and has faced periodic challenges. It does not create a legal right to possess cannabis — the substance remains illegal under Belgian law. Rather, it is a prosecutorial discretion instrument, similar in concept to the Dutch gedoogbeleid, instructing enforcement authorities to focus resources elsewhere. Adults found with up to 3g in non-aggravating circumstances should receive only a simplified notice (proces-verbaal) rather than criminal prosecution.

Aggravating circumstances that could escalate a small possession case to criminal prosecution include: possession near schools or youth centers, possession by or in the presence of minors, or any indication of supply activity. Repeat encounters with the same individual can also escalate enforcement response.

The 2022 Cannabis Directive: One Plant Per Household

A significant additional development came in 2022 when Belgian authorities issued an updated directive explicitly extending the low-priority policy to home cultivation of one cannabis plant per household. This was not a legislative change — the underlying 1921 law still technically prohibits cultivation — but it represented an administrative acknowledgment that prosecution of single-plant household cultivation was disproportionate and not in the public interest.

The one-plant guideline placed Belgium in a more pragmatic position than many EU neighbours: a Belgian adult living alone could, in theory, cultivate a single cannabis plant for personal use without realistic fear of prosecution, as long as the plant remained within their own residence and showed no evidence of commercial activity.

The 2024 Directive Update: Further Reduction of Consequences

The most recent significant policy development came with the 2024 directive update from the Belgian Ministry of Justice. This update further clarified and strengthened the 3g threshold, explicitly stating that possession of up to 3g by an adult for clearly personal use should not result in even a simplified notice in most circumstances — moving the threshold from ’lowest priority’ to effectively ’no action.’

The 2024 update also reinforced guidance that police resources should focus on supply, trafficking, and situations involving minors rather than adult personal possession. Critics from law enforcement bodies argued that the directive removed too much discretion from officers on the ground; advocates for reform called it an overdue step toward decriminalization in substance rather than just in name.

It is critical to understand that none of these directives change the underlying law. Cannabis remains illegal in Belgium. The directives manage enforcement discretion but do not provide a legal right to possess, consume, or cultivate cannabis.

Cannabis Penalties Under Belgian Law

The Belgian Drug Act of 1921, as amended, establishes a framework of criminal penalties that apply when prosecutors do choose to pursue cases — particularly above the 3g threshold or in aggravating circumstances.

Enforcement Differences: Flanders vs. Wallonia vs. Brussels

Belgium’s federal structure — which divides the country between the Dutch-speaking Flemish Region, the French-speaking Walloon Region, and the bilingual Brussels-Capital Region — creates real-world enforcement variations that go beyond the national directive framework.

Flanders

The Flemish Region (Vlaanderen) tends to have more active and structured enforcement of drug laws generally. Flemish police forces have been more proactive in implementing drug testing at festivals and entertainment events, and Flemish prosecutors have historically been somewhat more likely to pursue cases at the lower end of the quantity spectrum than their Walloon counterparts. This reflects both cultural differences (Flanders has a strong civic-compliance tradition) and police capacity (Flemish local police forces tend to be better resourced than equivalents in rural Wallonia).

However, Flanders is not a uniformly strict enforcement environment. Major Flemish cities including Ghent, Antwerp, and Bruges have vibrant cannabis scenes with open consumption in parks and entertainment districts that police typically ignore absent other concerns.

Wallonia

French-speaking Wallonia generally shows more permissive enforcement in practice. Rural Walloon police forces are stretched thin and rarely prioritize cannabis enforcement absent other criminal activity. In Walloon cities including Liège and Namur, open cannabis use in public spaces is common and typically undisturbed. The Walloon Regional Government has also been more vocal than Flanders in advocating for national cannabis policy reform.

Brussels

The Brussels-Capital Region occupies a unique position. As the seat of EU institutions and NATO, Brussels has a cosmopolitan, international population and a correspondingly permissive social culture. Cannabis use is prevalent in the city’s parks (Bois de la Cambre, Parc du Cinquantenaire, Forest area) and is largely undisturbed by police. Brussels has also been the location of periodic policy discussions about establishing a regulated cannabis dispensary pilot — similar to what Switzerland has introduced with its cannabis pilot programmes.

Medical Cannabis Access in Belgium

Belgium has one of the most restrictive medical cannabis frameworks among Western European countries. Unlike Germany (which legalized medical cannabis in 2017 and recreational use in 2024), Italy (which has an active medical cannabis programme), and even Luxembourg (which is developing a regulated market), Belgium has moved slowly on medical access.

Current legal medical cannabis options in Belgium are limited to two pharmaceutical-grade medicines:

• Sativex (nabiximols) — approved by the Belgian Federal Agency for Medicines and Health Products (FAMHP) in 2012 for symptom improvement of spasticity in multiple sclerosis. Sativex contains approximately equal proportions of THC and CBD in oromucosal spray form. A neurologist’s prescription is required, and coverage by the Belgian health insurance system (INAMI/RIZIV) is partial and subject to conditions.
• Epidiolex (cannabidiol) — EMA-approved for Dravet syndrome and Lennox-Gastaut syndrome. Epidiolex is a pharmaceutical-grade CBD product with essentially no THC. It is accessible through hospital specialists (pediatric neurologists) for children with drug-resistant epilepsy. Belgian health insurance covers Epidiolex under specific protocols.

There is no provision under Belgian law for patients with other conditions — chronic pain, anxiety, PTSD, insomnia, cancer-related symptoms — to legally obtain cannabis therapeutically through a pharmacy or dispensary. Such patients exist in a grey zone: they may use cannabis under the 3g decriminalization framework but have no legal supply channel and no insurance coverage.

The Brussels Cannabis Club Discussion

In 2022-2023, Brussels Region politicians engaged in serious discussions about establishing a regulated cannabis social club model — similar to the Cannabis Social Clubs that operate in Spain — as a Brussels pilot project. The proposal involved allowing registered adults to collectively grow cannabis for personal use within a licensed, non-profit framework. The discussions generated media interest but had not resulted in concrete legislation as of the writing of this guide. Belgium’s complex governance (federal law governs drug enforcement; regional governments have limited competence on drug policy) creates structural barriers to regional pilot programmes.

Hemp and CBD Regulations

Industrial hemp cultivation is fully legal in Belgium under EU common agricultural policy for varieties with THC below 0.2%. Belgium has a small but growing hemp industry, with cultivation primarily in Flanders for fibre and seed applications. Belgian research institutions have also engaged in cannabis and hemp research under FAMHP scientific licenses.

The CBD market in Belgium is active and largely unregulated in practice. Following the European Court of Justice’s landmark Kanavape ruling in 2020 — which found that member states cannot prohibit the sale of CBD derived from legally grown EU hemp — Belgian authorities have not aggressively regulated CBD product sales. CBD oils, cosmetics, teas, edibles, and topicals are widely available in dedicated CBD shops across Belgian cities, in pharmacies, and online.

FAMHP has not issued comprehensive national CBD product regulations, meaning the market operates under general food safety and cosmetics legislation rather than a cannabis-specific framework. Products making specific medical claims would in theory require pharmaceutical licensing, but enforcement against the general CBD market has been minimal.

CBD flower (cannabis plant material with <0.2% THC) has been a more contested area. Belgian police have occasionally seized CBD flower products on the grounds that they are visually indistinguishable from illegal cannabis and that their THC content must be verified. This creates uncertainty for CBD retailers selling flower products rather than processed oils. Several Belgian CBD retailers have been subject to prosecutorial proceedings, though courts have generally found in their favour when products were properly documented as hemp-derived.

Real Enforcement Practices

Despite the 3g decriminalization threshold, cannabis enforcement in Belgium is not uniform. Several enforcement realities are worth understanding:

Festivals and events: Belgium’s vibrant festival scene (Tomorrowland, Pukkelpop, Rock Werchter, Gentse Feesten) has historically been a target of drug enforcement, including cannabis. Drug dog deployments at festival entrances are common. However, consumption within festival grounds, while technically illegal, is broadly tolerated by security and police once inside.

Driving under the influence: Cannabis-impaired driving is a serious enforcement priority in Belgium. Roadside saliva tests for THC have been deployed by Belgian police since 2010. Testing positive for THC metabolites — which can persist for days after use — can result in a driving licence suspension even if the driver shows no visible impairment. Belgian road safety laws take a zero-tolerance approach to drug presence while driving.

Public housing: Belgium’s significant social housing sector has its own rules. Many social housing contracts explicitly prohibit drug use in communal areas, and housing association rules can result in lease termination — a consequence entirely separate from criminal law but significant for residents.

Border crossings: Belgium’s borders with the Netherlands, France, Luxembourg, and Germany are internal EU borders with no routine customs checks. However, Belgian customs and federal police conduct targeted operations, particularly on vehicles entering from the Netherlands. Cannabis purchased in Dutch coffeeshops cannot legally be brought into Belgium.

Reform Trajectory: Where Is Belgium Heading?

Belgian public opinion on cannabis has shifted substantially over the past decade. Polls conducted in the early 2020s consistently showed majority support for some form of regulated adult-use cannabis market, particularly among younger Belgians and those in urban centres. The major parties — Flemish N-VA, Walloon PS, and the liberal MR — have variously expressed cautious openness to further reform, though none have made cannabis legalization a central policy commitment.

The political context matters: Belgian coalition governments are notoriously complex, typically involving parties from both language communities and multiple ideological positions. Drug policy reform, which tends to be politically divisive along cultural-conservative lines, is not typically the issue that coalition agreements are built around.

However, external pressure is increasing. Germany’s legalization of recreational cannabis in 2024 — which allows adults to possess and collectively grow cannabis — created political pressure across Western Europe for neighbours to consider their positions. With Germany legalizing across Belgium’s eastern border, French-speaking Belgium in particular faces questions about how to prevent cannabis tourism flows in the direction of German regulated consumption versus the Netherlands’ coffeeshops.

Belgian health authorities have also engaged seriously with the public health evidence on cannabis regulation. The Scientific Institute of Public Health (Sciensano) has published reports noting that a regulated market could allow for quality control, age verification, and tax revenue — arguments that have gained traction in policy debates even among officials who are cautious about liberalization.

Frequently Asked Questions